SBI Securities Co. Ltd. Invests $313,000 in Tilray Inc (NASDAQ:TLRY)

SBI Securities Co. Ltd. acquired a new position in Tilray Inc (NASDAQ:TLRY) during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 235,653 shares of the company’s stock, valued at approximately $313,000.

A number of other institutional investors have also made changes to their positions in the business. Creative Planning raised its position in Tilray by 36.6% during the third quarter. Creative Planning now owns 141,921 shares of the company’s stock worth $250,000 after acquiring an additional 38,054 shares in the last quarter. International Assets Investment Management LLC raised its position in Tilray by 335.3% during the third quarter. International Assets Investment Management LLC now owns 23,639 shares of the company’s stock worth $42,000 after acquiring an additional 18,208 shares in the last quarter. Wealth Enhancement Advisory Services LLC raised its position in Tilray by 22.6% during the third quarter. Wealth Enhancement Advisory Services LLC now owns 39,819 shares of the company’s stock worth $70,000 after acquiring an additional 7,339 shares in the last quarter. Concurrent Investment Advisors LLC bought a new stake in Tilray during the third quarter worth $110,000. Finally, Vista Capital Partners Inc. bought a new stake in Tilray during the third quarter worth $42,000. Institutional investors own 9.35% of the company’s stock.

Wall Street Analyst Weigh In

Separately, Canaccord Genuity Group upped their price target on shares of Tilray from $2.00 to $3.00 and gave the stock a “buy” rating in a research report on Monday, January 13th. Three investment analysts have rated the stock with a hold rating and two have assigned a buy rating to the company’s stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Hold” and a consensus target price of $2.70.

Tilray Price Performance

NASDAQ:TLRY opened at $0.72 on Thursday. Tilray Inc has a one year low of $0.64 and a one year high of $2.97. The company has a market cap of $673.52 million, a P/E ratio of -2.39 and a beta of 2.13. The firm’s fifty day moving average price is $1.10 and its two-hundred day moving average price is $1.40. The company has a debt-to-equity ratio of 0.10, a current ratio of 2.54 and a quick ratio of 1.58.

Tilray (NASDAQ:TLRY) last released its quarterly earnings data on Friday, January 10th. The company reported ($0.10) EPS for the quarter, missing the consensus estimate of ($0.03) by ($0.07). Tilray had a negative net margin of 30.95% and a negative return on equity of 4.40%. The company had revenue of $210.90 million during the quarter, compared to analyst estimates of $216.34 million. The company’s quarterly revenue was up 8.7% compared to the same quarter last year. Equities analysts expect that Tilray Inc will post -0.2 earnings per share for the current year.

About Tilray

Tilray, Inc engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand, and South Africa. Tilray, Inc is headquartered in Canada.